These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17255294)

  • 41. Comparative Gene Expression Profiling of Primary and Metastatic Renal Cell Carcinoma Stem Cell-Like Cancer Cells.
    Khan MI; Czarnecka AM; Lewicki S; Helbrecht I; Brodaczewska K; Koch I; Zdanowski R; Król M; Szczylik C
    PLoS One; 2016; 11(11):e0165718. PubMed ID: 27812180
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genomics of renal cell cancer: the biology behind and the therapy ahead.
    Jones J; Libermann TA
    Clin Cancer Res; 2007 Jan; 13(2 Pt 2):685s-692s. PubMed ID: 17255294
    [TBL] [Abstract][Full Text] [Related]  

  • 43. From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma.
    Arsanious A; Bjarnason GA; Yousef GM
    Mol Cancer; 2009 Mar; 8():20. PubMed ID: 19291329
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.
    Lam JS; Shvarts O; Leppert JT; Figlin RA; Belldegrun AS
    J Urol; 2005 Jun; 173(6):1853-62. PubMed ID: 15879764
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metastatic renal cell carcinoma: many treatment options, one patient.
    Rini BI
    J Clin Oncol; 2009 Jul; 27(19):3225-34. PubMed ID: 19470934
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Renal cell carcinoma: current status and emerging therapies.
    Nelson EC; Evans CP; Lara PN
    Cancer Treat Rev; 2007 May; 33(3):299-313. PubMed ID: 17329029
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Update on the biology and management of renal cell carcinoma.
    Dutcher JP
    J Investig Med; 2019 Jan; 67(1):1-10. PubMed ID: 30455223
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mutations in renal cell carcinoma.
    D'Avella C; Abbosh P; Pal SK; Geynisman DM
    Urol Oncol; 2020 Oct; 38(10):763-773. PubMed ID: 30478013
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNAs Associated with Von Hippel-Lindau Pathway in Renal Cell Carcinoma: A Comprehensive Review.
    Schanza LM; Seles M; Stotz M; Fosselteder J; Hutterer GC; Pichler M; Stiegelbauer V
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29165391
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Significance of gene expression analysis of renal cell carcinoma.
    Leppert JT; Pantuck AJ
    Expert Rev Anticancer Ther; 2006 Feb; 6(2):293-9. PubMed ID: 16445381
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Artificial Intelligence in Pathomics and Genomics of Renal Cell Carcinoma.
    Knudsen JE; Rich JM; Ma R
    Urol Clin North Am; 2024 Feb; 51(1):47-62. PubMed ID: 37945102
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genomics and epigenomics of renal cell carcinoma.
    Maher ER
    Semin Cancer Biol; 2013 Feb; 23(1):10-7. PubMed ID: 22750267
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Towards individualized therapy for metastatic renal cell carcinoma.
    Kotecha RR; Motzer RJ; Voss MH
    Nat Rev Clin Oncol; 2019 Oct; 16(10):621-633. PubMed ID: 30992569
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The genomics of renal cell carcinoma and its role in renal mass biopsy.
    Salami SS; George AK; Udager AM
    Curr Opin Urol; 2018 Jul; 28(4):383-391. PubMed ID: 29708949
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic pathways involved in carcinogenesis of clear cell renal cell carcinoma: genomics towards personalized medicine.
    Audenet F; Yates DR; Cancel-Tassin G; Cussenot O; Rouprêt M
    BJU Int; 2012 Jun; 109(12):1864-70. PubMed ID: 22035299
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Heterogeneous drug target expression as possible basis for different clinical and radiological response to the treatment of primary and metastatic renal cell carcinoma: suggestions from bench to bedside.
    Santoni M; Santini D; Massari F; Conti A; Iacovelli R; Burattini L; Tortora G; Falconi M; Montironi R; Cascinu S
    Cancer Metastasis Rev; 2014 Mar; 33(1):321-31. PubMed ID: 24337954
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Precision medicine from the renal cancer genome.
    Riazalhosseini Y; Lathrop M
    Nat Rev Nephrol; 2016 Nov; 12(11):655-666. PubMed ID: 27694978
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Current trends in the molecular classification of renal neoplasms.
    Young AN; Master VA; Amin MB
    ScientificWorldJournal; 2006 Dec; 6():2505-18. PubMed ID: 17619725
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Renal cell carcinoma deep sequencing: recent developments.
    Farber LJ; Furge K; Teh BT
    Curr Oncol Rep; 2012 Jun; 14(3):240-8. PubMed ID: 22535504
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.